New report demonstrates development of new medicines relies on private sector expertise and investment

America ’s biopharmaceutical companies are at the heart of a research and development (R&D) ecosystem that develops more innovative medicines than any other country in the world. Critical to this ecosystem is the working relationship between industry and government agencies like the National Institutes of Health (NIH), academic medical centers and community-based research sites to further the translation of basic research into important medical products. 
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Research and Development Intellectual Property Drug Cost Source Type: news